Glenmark Life Sciences Limited
NSE:GLS.NS
1188.85 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| -3,015.94 | 3,014.14 | -4,430.72 | 4,429.47 | -3,093.97 | 2,838.23 | -3,645.61 | 3,645.34 | -5,121.64 | 5,121.57 | -4,262.11 | 4,262.11 | -1,184.01 | 1,155.96 | 110.88 | -99.98 |
| Short Term Investments
| 6,031.88 | 905.48 | 8,861.44 | 718.99 | 6,187.94 | 964.78 | 7,291.22 | 293.24 | 10,243.28 | 51.46 | 8,524.22 | 141.66 | 2,368.02 | 241.64 | 0 | 199.96 |
| Cash and Short Term Investments
| 3,015.94 | 3,919.62 | 4,430.72 | 5,148.46 | 3,093.97 | 3,803.01 | 3,645.61 | 3,938.58 | 5,121.64 | 5,173.03 | 4,262.11 | 4,403.77 | 1,184.01 | 1,397.6 | 110.88 | 99.98 |
| Net Receivables
| 0 | 7,654.32 | 0 | 8,074.64 | 0 | 8,067.66 | 0 | 7,256.13 | 0 | 6,742.53 | 0 | 6,854.06 | 0 | 6,195 | 7,208.34 | 0 |
| Inventory
| 0 | 6,665.91 | 0 | 6,695.12 | 0 | 6,041.71 | 0 | 6,365.63 | 0 | 5,162.44 | 0 | 5,050.21 | 0 | 5,134.21 | 5,081.27 | 0 |
| Other Current Assets
| 0 | 920.14 | 0 | 848.6 | 0 | 591.01 | 0 | 1,287.27 | 0 | 567.84 | 0 | 729.92 | 0 | 1,477.19 | 1,356.34 | 0 |
| Total Current Assets
| 3,015.94 | 19,159.99 | 4,430.72 | 20,766.82 | 3,093.97 | 18,503.39 | 3,645.61 | 18,847.61 | 5,121.64 | 17,645.84 | 4,262.11 | 17,037.96 | 1,184.01 | 13,990.41 | 13,756.83 | 99.98 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 0 | 8,961.97 | 0 | 8,437.98 | 0 | 8,242.44 | 0 | 7,750.76 | 0 | 6,763.36 | 0 | 5,993.78 | 0 | 5,789.86 | 5,654.05 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 148.53 | 0 | 172.4 | 0 | 180.01 | 0 | 109.16 | 0 | 103.8 | 0 | 95.29 | 0 | 79.11 | 66.09 | 0 |
| Goodwill and Intangible Assets
| 0 | 148.53 | 0 | 172.4 | 0 | 180.01 | 0 | 109.16 | 0 | 103.8 | 0 | 95.29 | 0 | 79.11 | 66.09 | 0 |
| Long Term Investments
| 0 | -794.41 | 0 | -634.63 | 0 | 0.77 | 0 | 0.77 | 0 | -50.69 | 0 | -108.12 | 0 | -240.87 | 0.77 | 0 |
| Tax Assets
| 0 | 942.2 | 0 | 718.99 | 0 | 82.14 | 0 | 91.62 | 0 | 107.06 | 0 | 153.17 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -3,015.94 | 85.84 | -4,430.72 | 68.21 | -3,093.97 | 12.72 | -3,645.61 | 12.93 | -5,121.64 | 140.7 | -4,262.11 | 119.26 | -1,184.01 | 352.24 | 87.96 | -99.98 |
| Total Non-Current Assets
| -3,015.94 | 9,344.13 | -4,430.72 | 8,762.95 | -3,093.97 | 8,518.08 | -3,645.61 | 7,965.24 | -5,121.64 | 7,064.23 | -4,262.11 | 6,253.38 | -1,184.01 | 5,980.34 | 5,808.87 | -99.98 |
| Total Assets
| 0 | 28,504.12 | 0 | 29,529.77 | 0 | 27,021.47 | 0 | 26,812.85 | 0 | 24,710.07 | 0 | 23,291.34 | 0 | 19,970.75 | 19,565.7 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 0 | 3,686.61 | 0 | 3,852.07 | 0 | 3,965.61 | 0 | 3,949.05 | 0 | 3,244.04 | 0 | 2,491.13 | 0 | 2,225.95 | 2,881.66 | 0 |
| Short Term Debt
| 0 | 23.87 | 0 | 22.91 | 0 | 22.65 | 0 | 13.49 | 0 | 16.8 | 0 | 15.83 | 0 | 9,328.67 | 0.21 | 0 |
| Tax Payables
| 0 | 0 | 0 | 232.9 | 0 | 70.78 | 0 | 213.94 | 0 | 120.03 | 0 | 94.7 | 0 | 136.93 | 0 | 0 |
| Deferred Revenue
| 0 | 523.02 | 0 | 1,022.19 | 0 | 759.12 | 0 | 857.32 | 0 | 545.11 | 0 | 696.42 | 0 | -9,328.67 | 0 | 0 |
| Other Current Liabilities
| 0 | 154.23 | 0 | 92.86 | 0 | 296.76 | 0 | 150.54 | 0 | 34.01 | 0 | 33.4 | 0 | 9,988.45 | 9,988.79 | 0 |
| Total Current Liabilities
| 0 | 4,387.73 | 0 | 4,990.03 | 0 | 5,044.14 | 0 | 4,970.4 | 0 | 3,839.96 | 0 | 3,236.78 | 0 | 12,214.4 | 12,870.66 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 0 | 147.61 | 0 | 159.93 | 0 | 170.92 | 0 | 61 | 0 | 12.04 | 0 | 20.55 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | -462.44 | 0 | -424.34 | 0 | -354.51 | 0 | -314.95 | 0 | -253.98 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 487.85 | 0 | 462.44 | 0 | 424.34 | 0 | 354.51 | 0 | 314.95 | 0 | 253.98 | 0 | 228.88 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 157.71 | 0 | 462.44 | 0 | 424.34 | 0 | 354.51 | 0 | 314.95 | 0 | 253.98 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0 | 793.17 | 0 | 622.37 | 0 | 595.26 | 0 | 415.51 | 0 | 326.99 | 0 | 274.53 | 0 | 228.88 | 0 | 0 |
| Total Liabilities
| 0 | 5,180.9 | 0 | 5,612.4 | 0 | 5,639.4 | 0 | 5,385.91 | 0 | 4,166.95 | 0 | 3,511.31 | 0 | 12,443.28 | 12,870.66 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 245.05 | 0 | 245.05 | 0 | 245.05 | 0 | 245.05 | 0 | 245.05 | 0 | 245.05 | 0 | 19.6 | 19.6 | 0 |
| Retained Earnings
| 0 | 12,918.03 | 0 | 0 | 0 | 11,020.63 | 0 | 0 | 0 | 10,213.53 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 23,323.22 | 23,078.17 | 23,917.37 | 23,672.32 | 21,382.07 | 66.83 | 21,426.94 | 21,181.89 | 20,543.12 | 34.98 | 19,780.03 | 19,534.98 | 7,527.47 | 7,507.87 | 6,459.14 | 4,016.92 |
| Other Total Stockholders Equity
| 0 | -12,918.03 | 0 | 0 | 0 | 10,049.56 | 0 | 0 | 0 | 10,049.56 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 23,323.22 | 23,323.22 | 23,917.37 | 23,917.37 | 21,382.07 | 21,382.07 | 21,426.94 | 21,426.94 | 20,543.12 | 20,543.12 | 19,780.03 | 19,780.03 | 7,527.47 | 7,527.47 | 6,478.74 | 4,016.92 |
| Total Equity
| 23,323.22 | 23,323.22 | 23,917.37 | 23,917.37 | 21,382.07 | 21,382.07 | 21,426.94 | 21,426.94 | 20,543.12 | 20,543.12 | 19,780.03 | 19,780.03 | 7,527.47 | 7,527.47 | 6,478.74 | 4,016.92 |
| Total Liabilities & Shareholders Equity
| 23,323.22 | 28,504.12 | 23,917.37 | 29,529.77 | 21,382.07 | 27,021.47 | 21,426.94 | 26,812.85 | 20,543.12 | 24,710.07 | 19,780.03 | 23,291.34 | 7,527.47 | 19,970.75 | 19,349.4 | 4,016.92 |